(taurolidine and heparin) catheter lock solution Clinical Trials
2 recruitingDrug
Phase 31Phase 41
Showing 1–2 of 2 trials
Recruiting
Phase 3
Comparing The Safety And Efficacy Of DEFENCATH® In Reducing Central-Line Bloodstream Infections (CLABSIs) In Adults Receiving Total Parenteral Nutrition Through A Central Venous Catheter (CVC)
Central Line Associated Blood Stream Infections (CLABSI)
CorMedix200 enrolled15 locationsNCT06822426
Recruiting
Phase 4
Open-Label Study to Assess Safety and Time to Catheter-related Bloodstream Infections (CRBSI) in Subjects From Birth to < 18 Years of Age
Catheter-Related Infections
CorMedix36 enrolled4 locationsNCT06714864